相关实验视频
Updated: Jan 10, 2026

05:25
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
1.2K
冠状动脉慢性全闭的组织病理学及其与皮肤再通道化技术的相关性
Mariem A Sawan1, Rebecca Steinberg1, Aloke V Finn2
1Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA.
Interventional cardiology clinics
|November 23, 2025
概括
冠状动脉慢性全闭 (CTOs) 是复杂的,动态的病变. 了解它们的组织病理学,包括化和纤维化,对于成功的穿皮冠状动脉干预至关重要.
科学领域:
- 干预心脏病学 干预心脏病学
- 病理学 病理学 病理学
背景情况:
- 冠状动脉慢性全闭症 (CTOs) 被定义为冠状动脉完全阻塞, TIMI 0 流量为 3 个月或更长时间.
- 在干预心脏病学中,CTOs代表了高度具有挑战性的病变子集.
研究的目的:
- 阐明CTOs的组织病理学特征.
- 了解首席技术官的动态和不断变化的性质.
- 通过皮肤冠状动脉干预技术,将基因病理学见解与皮肤冠状动脉干预技术联系起来.
主要方法:
- 对CTO病变的组织病理学分析.
- 检查病变的组成,包括血栓形成,炎症,新血管化,纤维化和化.
- 评估化分布,血管层组成和组织纤维方向.
主要成果:
- CTO不是静态的,而是动态的,不断变化的实体.
- 损伤成分涉及血栓形成,炎症,新血管化,纤维化和化的复杂相互作用.
- 具体的特征,如化分布和纤维方向是关键.
结论:
- 对CTO的病理洞察力是现代皮肤穿透冠状动脉干预的基础.
- 了解CTO的动态性质和组成可以改善治疗策略.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
206
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
329
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
329
Coronary Artery Disease II: Pathophysiology
348
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
348

